| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |